TITLE

Management of Red Teeth in an International Patient with X-Linked Adrenoleukodystrophy

AUTHOR(S)
Petrova, Elena; Miller, Weston P.; Myers, Sandra L.; Karp, Jeffrey M.
PUB. DATE
November 2015
SOURCE
Pediatric Dentistry;Nov/Dec2015, Vol. 37 Issue 7, p550
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Childhood cerebral X-linked adrenoleukodystrophy is a progressive, central nervous system, and endocrine disorder that typically leads to total neurologic disability and, eventually, death without appropriate, timely medical therapy. Hematopoietic stem cell transplantation has been found effective in slowing cerebral deterioration and improving long-term survival. The purpose of this case report was to describe the multidisciplinary management of red, discolored, pulpally treated primary molars identified in a nine-year-old Russian boy with childhood cerebral X-linked adrenoleukodystrophy preparing for myeloablative conditioning chemotherapy followed by hematopoietic stem cell transplantation.
ACCESSION #
111875502

 

Related Articles

  • Early Use of Drastic Therapy. Weinberg, Kenneth I. // New England Journal of Medicine;5/19/2005, Vol. 352 Issue 20, p2124 

    Focuses on the treatment of Krabbe's disease, also known as globoid-cell leukodystrophy. Claim that Krabbe's disease is an inborn error of lipid metabolism; Impact of Krabbe's disease on the central nervous system; Potential for improved status following enzyme replacement; Details of the...

  • Dasatinib Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation for an Isolated Central Nervous System Blast Crisis in Chronic Myelogenous Leukemia. Nishimoto, Mitsutaka; Nakamae, Hirohisa; Koh, Ki-Ryang; Kosaka, Saori; Matsumoto, Kana; Morita, Kunihiko; Koh, Hideo; Nakane, Takahiko; Ohsawa, Masahiko; Hino, Masayuki // Acta Haematologica;2013, Vol. 130 Issue 2, p111 

    A 22-year-old male with Ph-positive chronic myelogenous leukemia (CML) was started on treatment with imatinib. After 12 months of therapy, he achieved a complete cytogenetic response (CCyR). Although the CCyR persisted in his bone marrow, he developed an isolated CML blast crisis in his central...

  • Evaluation of Retinoids for Induction of the Redundant Gene ABCD2 as an Alternative Treatment Option in X-Linked Adrenoleukodystrophy. Weber, Franziska D.; Weinhofer, Isabelle; Einwich, Angelika; Forss-Petter, Sonja; Muneer, Zahid; Maier, Harald; Weber, Willi H. A.; Berger, Johannes // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    X-linked adrenoleukodystrophy (X-ALD), the most common peroxisomal disorder, is a clinically heterogeneous disease that can manifest as devastating inflammatory cerebral demyelination (CALD) leading to death of affected males. Currently, the only curative treatment is allogeneic hematopoietic...

  • Folinic acid administration following MTX as prophylaxis for GVHD. Gratwohl, A. // Bone Marrow Transplantation;Aug2009, Vol. 44 Issue 4, p257 

    The article focuses on the significance of the administration of folinic acid after Methotrexate (MTX) for graft versus host disease (GHVD) prophylaxis in allogeneic hematopoietic stem cell transplantation (SCT). It cites a study showing that the administration varied very greatly. The study...

  • Non-endocrine late complications in children after allogeneic haematopoietic SCT. Faraci, M.; Békássy, A. N.; De Fazio, V.; Tichelli, A.; Dini, G. // Bone Marrow Transplantation;Jun2008 Supplement, Vol. 41, pS49 

    Non-endocrine events represent a heterogeneous group of complications occurring in children who survive long term after haematopoietic SCT. This review highlights the late sequel in a growing child. The preparative regimen itself with high-dose chemotherapy and/or radiotherapy (TBI) or the...

  • Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis. Wang, Jing; Zhan, Ping; Ouyang, Jian; Chen, Bing; Zhou, Rongfu; Yang, Yonggong // Medical Oncology;Sep2011, Vol. 28 Issue 3, p822 

    Randomized controlled trials (RCTs) have reported conflicting results on the impact of high-dose chemotherapy with autologous hematopoietic stem cell transplantation (HDCT) as the first-line treatment for patients with aggressive non-Hodgkin lymphoma (NHL). We performed a systematic...

  • High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma. Sauerbrey, A; Bielack, S; Kempf-Bielack, B; Zoubek, A; Paulussen, M; Zintl, F // Bone Marrow Transplantation;5/1/2001, Vol. 27 Issue 9, p933 

    In this report, we describe our experience with high-dose chemotherapy (HDC) and autologous stem cell transplantation (ASCT) in 15 children with relapsed osteosarcoma who were treated by members of the Cooperative Osteosarcoma Study Group. Eight patients received HDC after the first relapse, six...

  • Reimmunization after Therapy for Childhood Cancer. Chisholm, Julia C. // Clinical Infectious Diseases;3/1/2007, Vol. 44 Issue 5, p643 

    The article offers the author's perspectives on the effectiveness of Great Britain's reimmunization program that aimed to increase humoral immunity among patients who had undergone chemotherapy for childhood malignancy. The use of intensive chemotherapy and hematopoietic stem cell...

  • 3. Lymphoma.  // Bone Marrow Transplantation;3/2/2002 Supplement, Vol. 29 Issue 5, pS84 

    Bone Marrow Transplantation (2001) 29, Suppl. 2, S84–S93. DOI: 10.1038/sj/bmt/1703466

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics